Review: Neuraminidase inhibitors reduce symptomatic influenza; oseltamivir does not reduce hospitalizations
- PMID: 25329219
- DOI: 10.7326/0003-4819-161-8-201410210-02002
Review: Neuraminidase inhibitors reduce symptomatic influenza; oseltamivir does not reduce hospitalizations
Comment on
-
Neuraminidase inhibitors for preventing and treating influenza in adults and children.Cochrane Database Syst Rev. 2014 Apr 10;2014(4):CD008965. doi: 10.1002/14651858.CD008965.pub4. Cochrane Database Syst Rev. 2014. PMID: 24718923 Free PMC article.
Similar articles
-
Oseltamivir and zanamivir have limited effect on symptoms and do not reduce hospitalisation or serious complications of influenza.Evid Based Med. 2014 Dec;19(6):211. doi: 10.1136/ebmed-2014-110033. Epub 2014 Jul 1. Evid Based Med. 2014. PMID: 24985901 No abstract available.
-
Should neuraminidase inhibitors be prescribed for patients with influenza?Ann Emerg Med. 2014 Jan;63(1):54-5. doi: 10.1016/j.annemergmed.2013.07.495. Epub 2013 Aug 7. Ann Emerg Med. 2014. PMID: 23932720 No abstract available.
-
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.Sao Paulo Med J. 2014;132(4):256-7. doi: 10.1590/1516-3180.20141324t2. Sao Paulo Med J. 2014. PMID: 25055075 Free PMC article.
-
Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.Chem Rev. 2009 Sep;109(9):4398-438. doi: 10.1021/cr800449m. Chem Rev. 2009. PMID: 19537777 Review. No abstract available.
-
[Neuraminidase inhibitors and risk of H5N1 influenza].Ann Pharm Fr. 2007 Jan;65(1):50-7. doi: 10.1016/s0003-4509(07)90016-4. Ann Pharm Fr. 2007. PMID: 17299351 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical